Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
What Does Spx Level Tell You About Market distills the level into actionable insights about market breadth and momentum.
28,520 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
As MiCA tightens EU crypto rules, licensed platforms race to absorb deposits from non-compliant venues. european cryp...
SK Hynix moves to list in the U.S., challenging Micron for memory-chip dominance as AI-driven demand and cyclical dyn...
A rising domestic memory player is lining up a major public listing to challenge established DRAM leaders. Investors ...
As Madrigal prepares to report its 2025 earnings, investors weigh pipeline progress, cash runway, and milestones ahea...
Nebius Group shows a dramatic jump in revenue as AI demand accelerates. This article explains the drivers, checks the...
Celebrity wellness stories grab headlines, but behind the flash are real costs and tricky choices. This article break...
A famous K-pop star’s stalker case isn’t just a headline. It exposes the hidden costs of personal security, legal bat...
February brought a sharp pullback for Robinhood, driven by crypto swings and a broader shift in its business model. T...
Oracle has faced skepticism around AI spending and cloud growth. This article digs into how Oracle's AI-Fueled Growth...
As the bitcoin depot (btm) 2025 story unfolds, investors want clarity on growth, margins, and risk. This article brea...
Explore how Pixelworks PXLW 2026 earnings shape a small-cap tech stock. This guide breaks down the key metrics, poten...